FDA — authorised 23 August 1996
- Application: BLA020604
- Marketing authorisation holder: EMD SERONO
- Local brand name: SEROSTIM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Serostim® on 23 August 1996
Yes. FDA authorised it on 23 August 1996.
EMD SERONO holds the US marketing authorisation.